182 related articles for article (PubMed ID: 9758341)
81. The clearance time of infused hematopoietic stem cell from the blood circulation.
Donmez A; Ozsan F; Arik B; Ozkayin N; Cagirgan S; Mir S; Vural F; Tombuloglu M
Transfus Apher Sci; 2013 Apr; 48(2):235-9. PubMed ID: 23428427
[TBL] [Abstract][Full Text] [Related]
82. Cost comparative study of autologous peripheral blood progenitor cells (PBPC) and bone marrow (ABM) transplantations for non-Hodgkin's lymphoma patients.
Woronoff-Lemsi MC; Arveux P; Limat S; Deconinck E; Morel P; Cahn JY
Bone Marrow Transplant; 1997 Dec; 20(11):975-82. PubMed ID: 9422478
[TBL] [Abstract][Full Text] [Related]
83. Patients at increased risk for late engraftment after transplantation: a novel method for their identification.
Mick R; Williams SF; Bitran JD
Bone Marrow Transplant; 1990 Sep; 6(3):185-91. PubMed ID: 2252958
[TBL] [Abstract][Full Text] [Related]
84. Leukocyte count and risk of thrombosis in patients undergoing haematopoietic stem cell transplantation or intensive chemotherapy.
Stoffel N; Rysler C; Buser A; Gratwohl A; Tsakiris DA; Stern M
Thromb Haemost; 2010 Jun; 103(6):1228-32. PubMed ID: 20352161
[TBL] [Abstract][Full Text] [Related]
85. Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy.
Siena S; Schiavo R; Pedrazzoli P; Carlo-Stella C
J Clin Oncol; 2000 Mar; 18(6):1360-77. PubMed ID: 10715309
[TBL] [Abstract][Full Text] [Related]
86. In vitro collection and posttransfusion engraftment characteristics of MNCs obtained by using a new separator for autologous PBPC transplantation.
Snyder EL; Baril L; Cooper DL; Min K; Mechanic S; Stoddart L; Burtness B; Seagraves P; Debelak J; Gudino M; McCullough J
Transfusion; 2000 Aug; 40(8):961-7. PubMed ID: 10960524
[TBL] [Abstract][Full Text] [Related]
87. Overnight refrigerator storage of autologous peripheral progenitor stem cells without cryopreservation.
Donmez A; Cagirgan S; Saydam G; Tombuloglu M
Transfus Apher Sci; 2007 Jun; 36(3):313-9. PubMed ID: 17569591
[TBL] [Abstract][Full Text] [Related]
88. Decreased quality of peripheral blood progenitors collected after a peripheral blood progenitor transplant.
Miller A; Morrison D; Safah H; Cullins S; Larussa V; Rink J; Weiner R
J Hematother Stem Cell Res; 2000 Aug; 9(4):475-80. PubMed ID: 10982245
[TBL] [Abstract][Full Text] [Related]
89. Peripheral blood progenitor cell transplantation in France.
Reiffers J; Faberes C; Tanguy ML
Nouv Rev Fr Hematol (1978); 1995; 37(6):321-5. PubMed ID: 8907626
[TBL] [Abstract][Full Text] [Related]
90. Factors affecting autologous peripheral blood stem cell collection in patients with relapsed or refractory diffuse large cell lymphoma and Hodgkin lymphoma: a single institution result of 168 patients.
Akhtar S; Weshi AE; Rahal M; Khafaga Y; Tbakhi A; Humaidan H; Maghfoor I
Leuk Lymphoma; 2008 Apr; 49(4):769-78. PubMed ID: 18398746
[TBL] [Abstract][Full Text] [Related]
91. High platelet contamination in progenitor cell concentrates results in significantly lower CD34+ yield after immunoselection.
Reiser M; Draube A; Scheid C; Fuchs M; Josting A; Diehl V; Söhngen D
Transfusion; 2000 Feb; 40(2):178-81. PubMed ID: 10686001
[TBL] [Abstract][Full Text] [Related]
92. Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients.
Zubair AC; Grant R; Wu W; Tun H; Rivera C; Moreno-Aspitia A; Joyce M; Roy V; Colon-Otero G; Solberg LA
Transfusion; 2008 Jun; 48(6):1106-14. PubMed ID: 18315528
[TBL] [Abstract][Full Text] [Related]
93. Peripheral blood progenitor cells: enabling outpatient transplantation.
McGuire TR; Tarantolo S; Reed E
Pharmacotherapy; 1998; 18(1 Pt 2):17S-23S. PubMed ID: 9473175
[TBL] [Abstract][Full Text] [Related]
94. CD34+ subset and tumor cell quantitation by flow cytometry--step toward quality assessment of autografts in B cell malignancies.
Johnsen HE; Rasmussen T; Knudsen LM
Vox Sang; 1998; 74 Suppl 2():477-82. PubMed ID: 9704485
[TBL] [Abstract][Full Text] [Related]
95. Cytological and cytochemical study of the peripheral blood mononuclear cells in leukapheresis products mobilized with rhG-CSF.
Villegas A; González FA; Armada B; Llorente L
Bone Marrow Transplant; 1996 Dec; 18(6):1199. PubMed ID: 8971397
[No Abstract] [Full Text] [Related]
96. Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient CD34+ cell yield.
Demirer T; Ilhan O; Ayli M; Arat M; Dagli M; Ozcan M; Haznedar R; Genc Y; Fen T; Ayyildiz E; Dincer S; Arslan O; Gurman G; Konuk N; Dalva K; Uysal A; Koc H; Ozet G; Akan H
Ther Apher; 2002 Oct; 6(5):384-9. PubMed ID: 12423534
[TBL] [Abstract][Full Text] [Related]
97. Autologous stem cell transplantation: release of early and late acting growth factors relates with hematopoietic ablation and recovery.
Testa U; Martucci R; Rutella S; Scambia G; Sica S; Benedetti Panici P; Pierelli L; Menichella G; Leone G; Mancuso S
Blood; 1994 Nov; 84(10):3532-9. PubMed ID: 7949108
[TBL] [Abstract][Full Text] [Related]
98. CD34+/CD90+ cells infused best predict late haematopoietic reconstitution following autologous peripheral blood stem cell transplantation.
Sumikuma T; Shimazaki C; Inaba T; Ochiai N; Okano A; Hatsuse M; Ashihara E; Nakagawa M
Br J Haematol; 2002 Apr; 117(1):238-44. PubMed ID: 11918561
[TBL] [Abstract][Full Text] [Related]
99. Thrombopoietin levels in patients undergoing autologous peripheral blood stem cell transplantation.
Yoshimura C; Nomura S; Katsura K; Yamaguchi K; Fukuhara S
Vox Sang; 2000; 78(2):106-12. PubMed ID: 10765146
[TBL] [Abstract][Full Text] [Related]
100. Immune reconstitution following transplantation of autologous peripheral CD34+ cells.
Sica S; Laurenti L; Sorà F; Menichella G; Rumi C; Leone G; Rutella S
Acta Haematol; 2001; 105(3):179-87. PubMed ID: 11463993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
